IMU 5.08% 6.2¢ imugene limited

MaxCyte and Imugene, page-24

  1. COD
    1,041 Posts.
    lightbulb Created with Sketch. 216

    MaxCyte rises on collaboration with Imugene for cancer medicines

    ** Shares of cell engineering firm MaxCyte MXCT.O rise ~4.2% to $5.18

    ** Firm says it signed an agreement allowing Imugene IMU.AX to use MaxCyte's Flow Electroporation technology and ExPERT platform to develop its cancer medicines

    ** Says it is entitled to receive platform licensing fees and program-related revenue in return

    ** Up to last close, stock down 9.3% in the last 12 months



    Reporting by Christy Santhosh


 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.003(5.08%)
Mkt cap ! $455.6M
Open High Low Value Volume
5.8¢ 6.5¢ 5.7¢ $1.751M 28.44M

Buyers (Bids)

No. Vol. Price($)
6 660964 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 549788 5
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.